Related Experiment Video
Updated: Sep 11, 2025

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
Synthesis and Evaluation of 2‑Substituted Quinazolin-4(3H)‑ones as Potential Antileukemic Agents
Giorgio Antoniolli1, Keli Lima2, Gilberto Carlos Franchi3
1Institute of Chemistry, University of Campinas, Campinas, SP 13083-862, Brazil.
Abstract:
The increasing life expectancy and rising prevalence of cancer emphasize the need for innovative therapeutic strategies. Targeted therapies have revolutionized cancer treatment by offering greater specificity and reduced toxicity compared to traditional cytotoxic drugs. Acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), remain aggressive malignancies with poor outcomes, particularly in elderly patients. Despite advancements, resistance to chemotherapy and adverse effects necessitate the discovery of novel antitumor compounds. Quinazolines, a versatile class of heterocyclic compounds, exhibit diverse biological activities, including anticancer properties. In this study, 20 derivatives of 2-substituted quinazolin-4-(3H)-ones were synthesized via condensation of 2-aminobenzamide with aldehydes in dimethyl sulfoxide. The compounds were characterized using IR, 1H NMR, and 13C NMR spectroscopy. Biological evaluation revealed that compounds 6 and 17 exhibited potent cytotoxic effects against T cell ALL (jurkat cells) and AML of promyelocytic subtype (APL) NB4 cells, with compound 17 showing IC50 values below 5 μM in both cell types. Compound 6 demonstrated selectivity for Jurkat cells. Further in vitro analyses, including apoptosis/cycle cell assays and pharmacokinetic predictions, confirmed their therapeutic potential. The data open new perspectives for "in vivo" studies concerning the application of quinazolin-4-(3H)-ones in treatment of acute leukemias of lymphoid and myeloid origins.
Insights
Novel quinazolinone derivatives show promise as targeted therapies for acute leukemias. Compounds 6 and 17 demonstrated significant cytotoxic effects against T cell acute lymphoblastic leukemia and acute myeloid leukemia cell lines.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Biology
Background:
- Rising cancer prevalence and aging populations necessitate novel therapeutic strategies.
- Acute leukemias (ALL, AML) are aggressive, with poor outcomes, especially in elderly patients.
- Chemotherapy resistance and toxicity drive the search for new antitumor agents.
Purpose of the Study:
- To synthesize and evaluate novel 2-substituted quinazolin-4-(3H)-one derivatives as potential anticancer agents.
- To investigate the cytotoxic activity of these compounds against acute leukemia cell lines.
- To explore the therapeutic potential of promising candidates for lymphoid and myeloid leukemias.
Main Methods:
- Synthesis of 20 quinazolinone derivatives via condensation reactions.
- Characterization using IR, 1H NMR, and 13C NMR spectroscopy.
- In vitro biological evaluation including cytotoxicity assays (IC50), apoptosis, and cell cycle analysis.
Main Results:
- Compounds 6 and 17 exhibited potent cytotoxic effects against Jurkat (T cell ALL) and NB4 (APL) cells.
- Compound 17 showed IC50 values below 5 μM in both cell lines.
- Compound 6 displayed selectivity towards Jurkat cells, with further in vitro analyses confirming therapeutic potential.
Conclusions:
- The synthesized quinazolin-4-(3H)-one derivatives, particularly compounds 6 and 17, show significant promise for treating acute leukemias.
- These findings support further in vivo investigation for the application of quinazolinones in lymphoid and myeloid leukemias.
- The study highlights the potential of quinazolinone scaffolds in developing targeted therapies for aggressive hematological malignancies.
Related Concept Videos
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
Aryldiazonium Salts to Azo Dyes: Diazo Coupling

